Zdrowie i gospodarka · 03/07/2019
FDA Clears THAM Solution (Tromethamine) Injectable for Approval
The FDA has determined that tromethamine injectable, 3.6g/100mL, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications (ANDAs) for this product.
Source: Federal Register — Food and Drug AdministrationOpen original release →